FUJIFILM Diosynth Biotechnologies Capacity Update April 2025: Fill/Finish

Henrik Herrmann, Executive Director of Technology and Business Development for Drug Product and Finished Goods at FUJIFILM Diosynth Biotechnologies (FDB), will provide an update on the current and future state of FDB’s Drug Product and Finished Goods capabilities. His presentation will highlight FDB’s comprehensive end-to-end CDMO services, detail the latest developments and expansions in Drug Product and Finished Goods capacity, and showcase recent work and strategic partnerships that are helping to advance client programs from development through commercialization.